Genetic Testing and Family Screening: Unlocking the HCM Treatment Market
Hypertrophic cardiomyopathy is often inherited, with first-degree relatives of affected individuals facing a 50% chance of carrying the same genetic mutation. Yet many people with HCM-causing mutations remain undiagnosed until symptoms appear—or worse, until a catastrophic event occurs. Genetic testing and family screening are essential for early identification, enabling timely...
0 Commentarii 0 Distribuiri 36 Views 0 previzualizare